In summary, our study demonstrated that Sam68 expression is strikingly associated with the apoptotic effect of sunitinib and may be a biomarker for sunitinib sensitivity in ccRCC patients. This evidence concerns the gene KHDRBS1 and nonpapillary renal cell carcinoma.